tradingkey.logo

Gelteq Ltd

GELS
0.806USD
+0.006+0.76%
Close 02/06, 16:00ETQuotes delayed by 15 min
8.63MMarket Cap
LossP/E TTM

Gelteq Ltd

0.806
+0.006+0.76%

More Details of Gelteq Ltd Company

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Gelteq Ltd Info

Ticker SymbolGELS
Company nameGelteq Ltd
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)
Number of employees7
Security typeOrdinary Share
Fiscal year-endOct 29
AddressLevel 4
CityMELBOURNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryAustralia
Postal code3205
Phone61390873990
Websitehttps://www.gelteq.com
Ticker SymbolGELS
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)

Company Executives of Gelteq Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
Other
52.47%
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
Other
52.47%
Shareholder Types
Shareholders
Proportion
Individual Investor
41.53%
Corporation
6.00%
Investment Advisor
0.53%
Research Firm
0.34%
Other
51.60%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
8
105.80K
1.05%
--
2025Q3
8
105.80K
1.05%
--
2025Q2
8
105.80K
1.09%
+654.00
2025Q1
5
105.14K
0.84%
+24.19K
2024Q4
3
80.95K
0.00%
+80.95K

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Markoff (Jeffrey)
2.44M
22.79%
--
--
Jun 30, 2025
Golik (David)
1.01M
9.45%
--
--
Jun 30, 2025
Givoni (Nathan Jacob)
657.09K
6.13%
--
--
Jun 30, 2025
Crestmont Pty Ltd
642.32K
6%
--
--
Jun 30, 2025
Szewach (Simon Hayden)
338.20K
3.16%
--
--
Jun 30, 2025
Susquehanna International Group, LLP
41.55K
0.39%
+41.55K
--
Sep 30, 2025
Wedbush Securities, Inc.
20.00K
0.19%
--
--
Sep 30, 2025
Virtu Americas LLC
15.47K
0.14%
+3.23K
+26.42%
Sep 30, 2025
HRT Financial LP
15.44K
0.14%
-29.18K
-65.40%
Sep 30, 2025
Morgan Stanley & Co. LLC
651.00
0.01%
+651.00
--
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI